Devices/Safety Alert·openFDA/device

INSET II (UNOMEDICAL DEVICES S.A DE C.V) — Malfunction

MediumPublished May 31, 2026· AI-analyzed Jun 8, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

A malfunction event was reported involving the INSET II device, manufactured by UNOMEDICAL DEVICES S.A DE C.V.

Who it affects

This affects manufacturers of infusion set devices, specifically UNOMEDICAL DEVICES, and professionals responsible for device performance monitoring and patient safety reporting.

Why it matters

While the source provides limited detail regarding the nature of the malfunction, such reports typically indicate a failure of the device to meet its performance specifications. Regulatory teams may need to evaluate whether this is an isolated incident or part of a broader trend requiring CAPA investigation or labeling updates.

Practical takeaway

Regulatory and quality teams should ensure that post-market surveillance systems are capturing all malfunction reports and that risk management files are updated to reflect the frequency and nature of these events. Performance of infusion sets should be monitored for trends that may necessitate further corrective action.

FDA source material

Event type: Malfunction. Device: INSET II by UNOMEDICAL DEVICES S.A DE C.V.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.